Description
BellyShred — GLP-1 Companion Program
BellyShred combines Tesamorelin (FDA-approved for visceral fat reduction) with Ipamorelin to target stubborn abdominal fat that GLP-1 medications don’t always touch. Designed as a stack-on for patients on Semaglutide or Tirzepatide who want to attack belly fat directly while preserving lean muscle.
✅ May support visceral (abdominal) fat reduction
✅ May support lean body mass preservation during weight loss
✅ Pairs with GLP-1 weight loss programs (Semaglutide / Tirzepatide)
✅ Provider-reviewed peptide therapy
✅ Prescription filled by U.S.-based pharmacies
✅ Injection supplies included with our CoraDoc Triple Free Promise
✅ No memberships • No office visits • No hidden fees
0% financing available • HSA/FSA eligible
Compounded peptides are prescription medications that may be prescribed only after review by a licensed healthcare provider. These compounded medications are not FDA-approved as finished drug products. Medications are dispensed by CoraDoc’s licensed U.S. compounding partner pharmacies. Results vary based on dosage, adherence, and individual health factors. Your licensed provider will work with you to determine if peptide therapy is appropriate for your individual health profile and goals.
